Arena Pharmaceuticals Inc (ARNA.A)

ARNA.A on American Stock Exchange

27 Mar 2015
Change (% chg)

$0.00 (+0.02%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ARNA.A


Arena Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. The Company’s drug, BELVIQ (lorcaserin HCl), was approved by the United States Food and Drug Administration for chronic weight management in adults. The Company also has... (more)


Beta: -0.52
Market Cap(Mil.): $1,045.54
Shares Outstanding(Mil.): 241.46
Dividend: --
Yield (%): --


  ARNA.A Industry Sector
P/E (TTM): -- 132.14 40.89
EPS (TTM): -0.28 -- --
ROI: -25.31 -0.52 16.10
ROE: -86.94 -2.20 16.95
Search Stocks

After slam dunk, NBA eyes growth in Mexico but no franchise yet

MEXICO CITY - Delighted following a packed house at Wednesday's regular clash between the Houston Rockets and Minnesota Timberwolves, the NBA is eyeing further growth in Mexico next year but any eventual franchise south of the border is still some ways off.

14 Nov 2014


Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks